CD Bioparticles launched a variety of strong and weak Ion Exchange Magnetic Particles to separate proteins, peptides, antibodies, DNA/RNA, and other biomolecules.
Creative Diagnostics recently introduced Hemagglutination Assay services for influenza vaccine, diagnostic, and surveillance communities to measure virus and antibody titers and monitor influenza subtypes.
Creative Diagnostics announced the launch of a panel of anti-PEG IgG or IgM ELISA kits with different species reactivity to detect anti-PEG IgG or IgM in serum and plasma.
CD Bioparticles launched a range of near-infra-red (NIR) quantum dots that exhibit excellent optical properties and biocompatibility for biomedical imaging.
Amerigo Scientific recently announced the launch of its new polyclonal antibody to human blood coagulation factor XIII for the detection of blood coagulation factor XIII.
Clinion is anticipating the world’s leading clinical research specialists to participate in the ISCR 3rd Autumn Conference, with the purpose of stepping into a brand-new era of clinical trial innovation! HICC, Novotel, Hyderabad, Telangana, India, 17 September 2022
HMC TECHNOLOGIES is proud to be a bit unusual amongst our competitors. In fact, there’s really not another company like us. HMC TECHNOLOGIES plans to design, manufacture and supply Smart indoor grow products for both consumer and commercial plant growers. We conduct research and micro propagation (including tissue culture media, plant growth regulators, agars, biochemical and much more).
CD BioSciences introduces a series of Genetic Polymorphism services for the study of GPCR polymorphisms to support customers focused on basic research and drug development process.
CD Bioparticles introduces a series of Heparins products to support drug delivery research, such as the Heparin Biotin, Heparin Amine, and Heparin Thiol.
Satisfied Users & 
Approved Press Releases
